MOSCOW, Russia (AFP) — One of the developers of Russia’s Sputnik V coronavirus vaccine announced Friday that India-based drugmaker Hetero will produce over 100 million doses of the jab. “Hetero, one of India’s leading generic pharmaceutical companies, have agreed to produce in India over 100 million doses per year of the world’s first registered vaccine against the novel coronavirus infection -– Sputnik V,” the Russian Direct Investment Fund (RDIF) said in a statement, adding […]